Abstract:Exosomal miR‐1290 induces the downregulation of Akt2 expression and activation of the Akt2 downstream signaling pathway to polarize M2 macrophages. A, Localization of MiR1290 in Huh7 cells was visualized by FISH. MiR1290 probes were tagged with FAM (green) and DAPI (blue) was identified as nuclei. B, The TargetScan website was used to predict the binding site of miR‐1290 in the Akt2 3′UTR. A luciferase reporter assay with sea cucumber luciferin as the standardized internal reference was performed after cotransfection of a wild‐type/mutant Akt2 3′UTR and miR‐1290 mimic into 293T cells for 24 h. C and E, The protein expression of Akt2 and the downstream signaling pathway molecule C/EBP‐β in macrophages transfected with the miR‐1290 mimic/inhibitor was measured by Western blotting using GAPDH as the standardized control. D and F, An in vitro Transwell assay detected the effect of macrophages transfected with the miR‐1290 inhibitor in combination with the application of an Akt2 inhibitor on 97H hepatocellular carcinoma cell migration, as well as the morphology of the migrating cells. G, The protein expression of GAPDH (internal control) was measured by Western blotting to detect the effect of miR‐1290‐transfected macrophages treated with an Akt2 inhibitor on EMT protein markers in hepatocellular carcinoma cells; densitometry was also performed. The data are shown as the mean of three independent experiments (*, P < 0.05). Hypoxia plays an important role in the metastasis of hepatocellular carcinoma (HCC). Exosomes have been widely studied as mediators of communication between tumours and immune cells. However, the specific mechanism by which hypoxic HCC cell‐derived exosomes suppress antitumor immunity is unclear. Hypoxia scores were determined for The Cancer Genome‐Liver Hepatocellular Carcinoma (TCGA‐LIHC) dataset patients, and HCC patients in the hyperhypoxic group had a higher degree of M2 macrophage infiltration. Patients in the M2 high‐invasion group had a lower probability of survival than those in the low‐invasion group. In vivo and in vitro experiments demonstrated that exosomes secreted by hypoxic HCC cells promote M2 macrophage polarization. This polarization induces apoptosis in CD8+ T cells. Additionally, it encourages epithelial–mesenchymal transition (EMT), which increases HCC migration. Exosomal miRNA sequencing revealed that miR‐1290 was highly expressed in exosomes secreted by hypoxic HCC cells. Mechanistically, miR‐1290 in macrophages inhibited Akt2 while upregulating PD‐L1 to promote M2 polarization, induce apoptosis in CD8+ T cells, and enhance EMT in HCC. Animal studies found that the miR‐1290 antagomir in combination with the immune checkpoint inhibitor produced better antitumor effects than the monotherapies. In conclusion, the secretion of exosome‐derived miR‐1290 from HCC cells in a hypoxic environment supported immune escape by HCC cells by promoting M2 macrophage polarization to induce apoptosis in CD8+ T cells and enhance EMT that promoted HCC metastasis. Therefore, miR‐1290 is an important molecule in antitumor immunity in HCC, and inhibition of miR‐1290 could provide a novel immunotherapeutic approach for HCC treatment.

Exosomal miR-452-5p Induce M2 Macrophage Polarization to Accelerate Hepatocellular Carcinoma Progression by Targeting TIMP3

Hepatocellular Carcinoma Cell-Derived Exosomal miR-21-5p Induces Macrophage M2 Polarization by Targeting RhoB

Hepatocellular carcinoma cell-derived exosomal miR-21-5p promotes the polarization of tumor-related macrophages (TAMs) through SP1/XBP1 and affects the progression of hepatocellular carcinoma

M2 macrophage-secreted exosomes promote metastasis and increase vascular permeability in hepatocellular carcinoma

Exosomal miR-200b-3p induce macrophage polarization by regulating transcriptional repressor ZEB1 in hepatocellular carcinoma

Tumor-derived exosomal miR-934 induces macrophage M2 polarization to promote liver metastasis of colorectal cancer

Exosomal SLC16A1-AS1-induced M2 macrophages polarization facilitates hepatocellular carcinoma progression

RETRACTED ARTICLE: Exosomal DLX6-AS1 from hepatocellular carcinoma cells induces M2 macrophage polarization to promote migration and invasion in hepatocellular carcinoma through microRNA-15a-5p/CXCL17 axis

Exosomal miR-106a-5p from highly metastatic colorectal cancer cells drives liver metastasis by inducing macrophage M2 polarization in the tumor microenvironment

LncRNA TP73-AS1/miR-539/MMP-8 axis modulates M2 macrophage polarization in hepatocellular carcinoma via TGF-β1 signaling.

MicroRNA-452 Promotes Tumorigenesis in Hepatocellular Carcinoma by Targeting Cyclin-Dependent Kinase Inhibitor 1B.

Exosomal miR-183-5p Shuttled by M2 Polarized Tumor-Associated Macrophage Promotes the Development of Colon Cancer via Targeting THEM4 Mediated PI3K/AKT and NF-κB Pathways

Exosomal Lncrna HEIH, an Essential Communicator for Hepatocellular Carcinoma Cells and Macrophage M2 Polarization Through the Mir-98-5p/stat3 Axis.

Mir-452-3p: A Potential Tumor Promoter That Targets the CPEB3/EGFR Axis in Human Hepatocellular Carcinoma

Exosome-depleted MiR-148a-3p derived from Hepatic Stellate Cells Promotes Tumor Progression via ITGA5/PI3K/Akt Axis in Hepatocellular Carcinoma

Exosomal miR-4800-3p Aggravates the Progression of Hepatocellular Carcinoma via Regulating the Hippo Signaling Pathway by Targeting STK25

Colorectal cancer tumor cell-derived exosomal miR-203a-3p promotes CRC metastasis by targeting PTEN-induced macrophage polarization

Exosomal lncRNA HMMR‐AS1 mediates macrophage polarization through miR ‐147a/ ARID3A axis under hypoxia and affects the progression of hepatocellular carcinoma

Hypoxic tumour‐derived exosomal miR‐1290 exacerbates the suppression of CD8+ T cells by promoting M2 macrophage polarization

Cancer Cell-Derived Exosomal Mir-500A-3p Modulates Hepatic Stellate Cell Activation and the Immunosuppressive Microenvironment.

Exosomal Mir-142-3p Secreted by Hepatitis B Virus (Hbv)-Hepatocellular Carcinoma (HCC) Cells Promotes Ferroptosis of M1-type Macrophages Through SLC3A2 and the Mechanism of HCC Progression.